Pharm
Parathyroid Hormone Analog
search
Parathyroid Hormone Analog
, Teriparatide, Forteo, Abaloparatide, Tymlos
Mechanism
Recombinant
Parathyroid Hormone
Significant bone anabolic activity
Indications
Severe
Osteoporosis
Women, postmenopausal, with severe bone loss
Men with
Osteoporosis
and high risk of
Fracture
Osteoporosis
refractory to
Bisphosphonates
Preparations
Abaloparatide (Tymlos)
Dose: 80 mcg SQ daily for up to 2 years
Teriparatide (Forteo)
Dose 20 mcg SQ daily for up to 2 years
Consider restarting bisphosphonate after Teriparatide course is completed
Black (2005) N Engl J Med 353(6):555-65 [PubMed]
Efficacy
Teriparatide (Forteo)
BMD increases 5.9% at spine and 1.5% at femoral neck
Reduced risk for osteoporotic
Fracture
s
Neer (2001) N Engl J Med 344:1434-41 [PubMed]
Contraindications
Hyperparathyroidism
Osteomalacia
End Stage Renal Disease
Bone Cancer
Active
Nephrolithiasis
Hypercalcemia
Osteosarcoma
risk
Paget's Disease
Prior skeletal radiation
Elevated
Alkaline Phosphatase
level
Adverse Effects
Common
Orthostatic Hypotension
Transient
Hypercalcemia
Nausea
Headache
Palpitation
s
Arthralgia
s
Leg Cramp
s
Uncommon (identified in rat studies)
Osteosarcoma
Precautions
Do not use with bisphosphonate
Use limited to 2 year maximum (due to risk of
Osteosarcoma
)
Very expensive agents ($20,000 per year or more)
Resources
National
Osteoporosis
Foundation Clinicians Guide To
Osteoporosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546973/
References
(2017) Presc Lett 24(7)
Campion (2003) Am Fam Physician 67(7):1521-6 [PubMed]
Orwoll (2003) J Bone Miner Res 18:9-17 [PubMed]
Type your search phrase here